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N E U R O S C I E N C E
Hypothalamic circuitry underlying stress-induced 
insomnia and peripheral immunosuppression
Shi-Bin Li1,2*, Jeremy C. Borniger1,2†, Hiroshi Yamaguchi1,2‡, Julien Hédou3,  
Brice Gaudilliere3, Luis de Lecea1,2*
The neural substrates of insomnia/hyperarousal induced by stress remain unknown. Here, we show that restraint 
stress leads to hyperarousal associated with strong activation of corticotropin-releasing hormone neurons in the 
paraventricular nucleus of hypothalamus (CRHPVN) and hypocretin neurons in the lateral hypothalamus (HcrtLH). 
CRHPVN neurons directly innervate HcrtLH neurons, and optogenetic stimulation of LH-projecting CRHPVN neurons 
elicits hyperarousal. CRISPR-Cas9–mediated knockdown of the crh gene in CRHPVN neurons abolishes hyperarousal 
induced by stimulating LH-projecting CRHPVN neurons. Genetic ablation of Hcrt neurons or crh gene knockdown 
significantly counteracts restraint stress–induced hyperarousal. Single-cell mass cytometry by time of flight 
(CyTOF) revealed extensive changes to immune cell distribution and functional responses in peripheral blood 
during hyperarousal upon optogenetic stimulation of CRHPVN neurons simulating stress-induced insomnia. 
Our findings suggest both central and peripheral systems are synergistically engaged in the response to stress via 
CRHPVN circuitry.
INTRODUCTION
A brief exposure to a stressor imposes a persistent imprint on the 
brain (1). Insomnia is among the most prevalent stress-related com-
plaints, and clarification of the mechanism underlying stress-induced 
insomnia is essential for developing effective treatment. Accumulated 
evidence has shown that wakefulness-promoting brain regions are 
involved in the neural response to stress (2). In addition, changes in 
adaptive and maladaptive immune responses have been empirically 
linked to stress exposure (3). However, the explicit neural circuitry 
integrating behavioral (e.g., insomnia) and physiological (e.g., im-
munosuppression) effects of stress remains unclear.
Stress induces insomnia/hyperarousal in humans (4) and rodent 
model (2). Transitions from sleep to wakefulness can be elicited upon 
optogenetic activation of the hypocretin/orexin (Hcrt) system (5), 
noradrenergic locus coeruleus (6), dopaminergic neurons in ventral 
tegmental area (VTA) (7) and dorsal raphe (8), and/or the cholinergic 
basal forebrain, among others (9, 10). Despite the strong evidence 
demonstrating a causal relationship between neuronal ensembles 
and behavioral wakefulness, whether these same neuronal popula-
tions are recruited during stress exposure remains unknown. Some 
arousal-promoting brain nuclei are preferably active during appeti-
tive sensory inputs. For example, fiber photometry recording from 
dopaminergic neurons in the VTA (7) and dorsal raphe nucleus (8) 
in male mice showed maximum activity during presence of palat-
able food and female mice, suggesting their association with posi-
tive valence. Furthermore, the observation that reward buffers the 
CRHPVN neuronal activities following footshock stressor (11) sug-
gests that the reward-related neuronal ensembles are unlikely im-
plicated in stress circuitry. Both positive and negative stimuli are 
able to elicit Hcrt neuronal activities (12). These studies indicate 
different arousal-promoting brain nuclei may mediate arousal in 
response to various stimuli depending on their respective valence 
(either positive or negative). A well-defined neural circuitry linking 
stress to arousal has yet to be adequately described.
Psychosocial stress has well-known effects on systemic immune 
responses (3). Specifically, chronic stressors suppress both cellular 
and humoral measures (13). For example, in a classic study of chron-
ically stressed caregivers of patients with dementia, Kiecolt-Glaser et al. 
observed marked decrements in three separate measures of cellular 
immunity (14). In animal models, psychological stress (e.g., via re-
straint stress) causes thymic involution (along with T cell apoptosis) 
and suppresses granulocyte and macrophage migration to the location 
of inflammatory challenge, putatively via a glucocorticoid-dependent 
mechanism (15). A major driver of immune responses to stressors 
are glucocorticoids secreted from the adrenal cortex, downstream 
of the hypothalamic-pituitary-adrenal (HPA) axis (16). CRHPVN 
neurons serve as the initial node in this axis, transducing the neuro-
nal signal of stress into an endocrine output (i.e., glucocorticoid se-
cretion). The actions of the HPA axis are fundamentally coupled to 
arousal, as sleep disruption powerfully drives HPA activation and 
glucocorticoid secretion in human (17). Despite the clear effects of 
stress and stress-induced arousal on the immune system, an understand-
ing of the neural circuitry underlying this phenomenon is lacking.
We hypothesized that insomnia/hyperarousal and peripheral im-
munosuppression may share the same neural substrates under stress. 
We performed a series of experiments with transgenic mice to test 
this hypothesis. After identifying that both stress-associated CRHPVN 
neurons and arousal-promoting HcrtLH neurons are activated by re-
straint stress, we demonstrated that HcrtLH neurons are monosyn-
aptically innervated by CRHPVN neurons. We then observed that the 
activity of CRHPVN neurons is not required for natural sleep-to-wake 
transitions but associates with stress exposure. Mild optogenetic 
stimulation of CRHPVN, but not HcrtLH neurons, elicited persistent 
wakefulness mimicking insomnia induced by restraint stress. Genetic 
ablation of Hcrt neurons or knockdown of crh gene in CRHPVN neu-
rons counteracted insomnia/hyperarousal induced by optogenetic 
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stimulation or restraint stress. Unbiased mass cytometry by time of 
flight (CyTOF) analysis revealed optogenetic stimulation of CRHPVN 
neurons leads to peripheral immunosuppression simulating the phys-
iological effect due to stress. These data suggest that connections be-
tween CRHPVN and HcrtLH neurons drive stress-induced insomnia, 
partially at least, and that activation of CRHPVN neurons is suffi-
cient to elicit stress-induced immunosuppression.
RESULTS
Restraint stress causes strong cFos expression in CRHPVN 
and HcrtLH neurons
To reveal the specific neuronal responses to stress exposure, we in-
vestigated the stress-related paraventricular nucleus of the hypo-
thalamus (PVN) and the arousal-related brain region the lateral 
hypothalamus (LH). We subjected mice to restraint stress, a well- 
established robust and noninvasive stress paradigm (18) and per-
formed cFos antibody staining at different time points following 
restraint stress. We found a large number of cells around the PVN 
and LH to be cFos positive (fig. S1), consistent with earlier work 
showing cFos activity upon exposure to cage exchange stress in rats 
(2). Antibody staining in the same slices revealed that the vast majority 
of PVN cFos-positive neurons coexpress corticotropin-releasing hor-
mone (CRH; also known as corticotropin-releasing factor), and a 
major population of LH cFos-positive neurons are hypocretinergic 
(fig. S1), a group of neurons that play a major role in promoting and 
stabilizing wakefulness (5).
CRHPVN neurons directly innervate HcrtLH neurons
The PVN consists of a constellation of several neuronal types in-
cluding those that secrete the neuropeptides CRH, arginine vaso-
pressin (AVP), and oxytocin (OXT) (19). It was unclear which cell 
type in the PVN directly makes synapses onto HcrtLH neurons, de-
spite previous reports that the PVN is an upstream partner of Hcrt 
neurons (12, 20). We used the EnvA-pseudotyped glycoprotein (G)– 
deleted rabies virus (EnvA + RVdG) system (21) to trace the mono-
synaptic inputs to Hcrt neurons and found a major population of 
PVN neurons directly projected to Hcrt neurons. We further per-
formed antibody staining in the PVN and found around 60% of the 
RVdG-labeled PVN neurons were CRH positive and about half of 
the CRHPVN neurons were labeled by the RVdG (Fig.  1,  A  to  E). 
AVP and OXT neurons, another two major populations of neurons 
intermingled with CRH neurons in the PVN (19), were labeled with 
a much lower ratio (Fig. 1, F  to  J  and K  to O). We then injected 
AAV-Retro vectors (22) carrying enhanced yellow fluorescent pro-
tein (eYFP) to the LH of CRH::Cre, AVP::Cre, and OXT::Cre mouse 
lines, respectively, and observed that nearly 70% of CRH neurons 
projected to the LH containing Hcrt neurons (fig. S2, A to E). Nota-
bly, about 60% AVP neurons were labeled by AAV-Retro vectors 
(fig. S2, F to J), suggesting AVPPVN neurons may target neuronal 
populations that are distinct from Hcrt neurons in the LH given the 
cell type–specific monosynaptic tracing of Hcrt neurons in Fig. 1. 
These two sets of experiments demonstrated CRHPVN neurons are 
the primary population targeting HcrtLH neurons, and established a 
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Fig. 1. CRHPVN neurons directly innervate HcrtLH neurons with monosynaptic contacts. (A to E) Representative slice containing PVN neurons labeled by RVdG (A), 
antibody staining against CRH (B), merged slice (C), cell counts of RVdG-labeled neurons, CRH-positive neurons and both-positive neurons (D), and percentages of 
RVdG-labeled neurons positive for CRH staining and CRH neurons labeled by RVdG (E). (F to J) Representative slice containing PVN neurons labeled by RVdG (F), antibody 
staining against AVP (G), merged slice (H), cell counts of RVdG-labeled neurons, AVP-positive neurons and both-positive neurons (I), and percentages of RVdG-labeled 
neurons positive for AVP staining and AVP neurons labeled by RVdG (J). (K to O) Representative slice containing PVN neurons labeled by RVdG (K), antibody staining 
against OXT (L), merged slice (M), cell counts of RVdG-labeled neurons, OXT-positive neurons and both-positive neurons (N), and percentages of RVdG-labeled neurons 









Li et al., Sci. Adv. 2020; 6 : eabc2590     9 September 2020
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
3 of 13
tracing strategies identified only limited OXT neurons projected to 
the LH (Fig. 1, K to O, and fig. S2, K to O), confirming earlier obser-
vations (23).
Activity of CRHPVN neurons is not a prerequisite for natural 
sleep-to-wake transitions
We then monitored the activity of CRHPVN neurons in CRH::Cre mice 
and HcrtLH neurons in Hcrt::Cre mice by measuring Ca2+ transients 
during natural sleep/wake transitions in their home cages using fi-
ber photometry (Fig. 2). CRHPVN neurons showed minimal changes 
in activity during natural sleep/wake transitions (Fig. 2, A to C). 
However, HcrtLH neurons were highly active during wakefulness 
(Fig. 2, D to F) independent of duration, confirming earlier findings 
(24, 25). These experiments demonstrated that activation of Hcrt 
neurons does not require CRHPVN neuronal activity during natural 
sleep-to-wake transitions.
Stress elicits strong CRHPVN and HcrtLH neuronal activity
We further investigated how CRHPVN and HcrtLH neurons change 
their activity in response to various salient stimuli involving novel-
ty, social, appetitive, and aversive components. Generally, aversive 
stimuli such as 2,3,5-trimethyl-3-thiazoline (TMT; a component of 
fox odor), restraint stress, open arm of the elevated plus maze (EPM), 
and manual grabbing triggered substantial CRHPVN neuronal activ-
ity, whereas neutral or appetitive stimuli including novelty (novel 
Falcon tube), female mice, high-fat diet (HFD) elicited CRHPVN neu-
ronal activity to a lesser extent (Fig. 3, A and B). The increase in 
CRHPVN neuronal activity upon aversive stimuli is consistent with 
previous work using aversive stimuli including forced swim test, tail- 
restraint test, overhead object, TMT, looming disk (26), and white 
noise (27). HcrtLH neurons displayed strong neuronal activity to var-
ious stimuli regardless of stimulus valence (Fig. 3, C and D). Notably, 
restraint stress triggered robust activity in both of CRHPVN and 
HcrtLH neurons especially at the beginning of restraint stress expo-
sure (Fig. 3, “Restraint” panel). Synergistic activation of CRHPVN and 
HcrtLH neurons during restraint stress is consistent with our obser-
vation of cFos staining as described in fig. S1.
Mild optogenetic stimulation of LH-projecting CRHPVN 
neurons leads to insomnia
Because CRHPVN neurons are sensitive to stressful stimuli, we hy-
pothesized that the neuronal circuitry connecting CRHPVN and HcrtLH 
neurons drives hyperarousal/insomnia in response to stress exposure. 
We thus conducted a series of optogenetic experiments in Hcrt::Cre 
(Fig. 4A), CRH::Cre (Fig. 4E), CRH::Cre-ATA3 mice (28), which have 
their Hcrt neurons ablated (Fig. 4I and fig. S3, E to H), and CRH::Cre- 
Cas9 mice with the crh gene disrupted using CRISPR-Cas9 technol-
ogy (29) in CRHPVN neurons (Fig. 4M and fig. S4). We used a mild 
optogenetic stimulation paradigm (i.e., 15-ms 473-nm blue light 
pulse at 0.1 Hz for 6 hours starting from the beginning of the light 
phase) with neglectable effects on HcrtLH neurons in changing the 
amount of sleep/wakefulness (Fig. 4, A to D and Q to S, and fig. S5, 
A and E). Notably, this same optogenetic stimulation of CRHPVN 
neurons labeled with ChR2-eYFP by AAV-Retro vectors injected to 
LH significantly increased the amount of wakefulness (†P < 0.0005; 
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Fig. 2. CRHPVN and HcrtLH neuronal activity during natural sleep/wake transitions. (A) Diagram of fiber photometry recording from CRHPVN neurons. (B) Representative 
EEG, EEG power spectra, EMG, and CRHPVN GCaMP trace recorded simultaneously during a 90-s natural sleep/wake transition episode from a CRH::Cre mouse. (C) No ob-
vious fluctuations of Ca2+ transients in CRHPVN neurons during natural sleep/wake transitions. (D) Diagram of fiber photometry recording from HcrtLH neurons. (E) Repre-
sentative EEG, EEG power spectra, EMG, and HcrtLH GCaMP trace recorded simultaneously during a 90-s natural sleep/wake transition episode from a Hcrt::Cre mouse. 
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insomnia/hyperarousal. This observation is consistent with earlier 
report that intracerebroventicular injection of CRH causes long- 
lasting wakefulness (30). Optogenetic stimulation of LH-projecting 
CRHPVN neurons of the CRH::Cre-ATA3 mice without Hcrt neu-
rons (fig. S3, E to H) also triggered a robust increase in wakefulness, 
but the effect was significantly smaller when compared with the con-
dition with intact Hcrt neurons (†P < 0.0005; Fig. 4, I to L and Q to S, 
and fig. S5, C and G). We further investigated whether CRH release 
is necessary for the optogenetically induced arousal response. We 
generated viruses carrying single guide RNAs (sgRNAs) to selec-
tively disrupt the crh gene in CRHPVN neurons of CRH::Cre-Cas9 
mice (fig. S4). Optogenetic stimulation of CRHPVN neurons project-
ing to LH from crh gene–disrupted mice failed to increase wakeful-
ness (Fig. 4, M to P and Q to S, and fig. S5, D and H), suggesting a 
critical role of CRH in activating downstream arousal-promoting 
brain nuclei including the HcrtLH neurons (31). Furthermore, we 
identified that CRH, AVP, and OXT neurons in the PVN are non- 
GABAergic as revealed by antibody staining in Vgat::Cre-tdTomato 
slices (fig. S6), supporting earlier studies demonstrating that CRHPVN 
neurons are glutamatergic/excitatory (32, 33).
Disruption of CRHPVN-HcrtLH circuitry compromises restraint 
stress–induced insomnia/hyperarousal
Given the observation of robust wakefulness upon optogenetic acti-
vation of LH-projecting CRHPVN neurons (Fig. 4 and fig. S5), we 
then evaluated whether the CRHPVN-HcrtLH pathway is relevant to 
hyperarousal/insomnia under stress. We subjected three genotypes 
of mice to restraint stress with intact or disrupted CRHPVN-HcrtLH 
neuronal circuitry. We monitored electroencephalography (EEG)/
electromyography (EMG) with a 10-min restraint session (18) in 
CRH::Cre mice, CRH::Cre-ATA3 mice with a genetic ablation of Hcrt 
neurons, and CRH::Cre-Cas9 mice with the crh gene disrupted 
bilaterally in PVN. A 10-min restraint stress session significantly 
delayed the nonrapid eye movement (NREM) and rapid eye move-
ment (REM) sleep onset (Fig. 5A). Either genetic ablation of Hcrt 
neurons or CRISPR-Cas9–mediated disruption of the crh gene in 
CRHPVN neurons significantly reduced the latency to NREM sleep 
onset compared with the mice with intact Hcrt neurons and crh gene, 
suggesting that these neurons play a synergistic role in stress-induced 
insomnia/hyperarousal. However, this acute 10-min restraint stress 
did not introduce notable changes to the general sleep/wake archi-
tecture in these three genotypes (Fig. 5, B to J). We further compared 
the basic sleep/wake patterns among these three genotypes and found 
significantly higher amount of REM sleep in CRH::Cre-ATA3 mice 
with Hcrt neurons ablated, and in CRH::Cre-Cas9 mice with dis-
rupted crh gene in CRHPVN neurons by sgRNAs (fig. S7, A to F). 
Higher amount of REM sleep in ATA3 mice confirmed earlier ob-
servation in the same ATA3 mouse line (34). The higher amount of 
REM sleep in CRH::Cre-Cas9 mice with disrupted crh gene appeared 
to be previously unidentified to the best of our knowledge. In addition, 
a single acute 10-min restraint stress did not change the pattern of 
difference observed in nonrestraint condition (fig. S7, G to L).
Optogenetic activation of CRHPVN neurons causes 
immunosuppression
As activation of stress circuitry drives changes in whole-body phys-
iology (i.e., “fight or flight” response), we investigated the immuno-
modulatory effects of CRHPVN neuron stimulation using single-cell 
mass CyTOF (35). We assessed changes in the distribution of circulat-
ing immune cells (Fig. 6) as well as alterations in intracellular signaling 
cascades (fig. S8) in response to a single session of CRHPVN optogenetic 
stimulation. CRH neuron stimulation resulted in marked alterations 
in peripheral immune cell distribution (Fig. 6B). Specifically, we ob-
served a reduction in the frequencies of natural killer (NK) cells, 
MHCII+ dendritic cells, inflammatory (Ly6CHi), patrolling (Ly6Clow) 
monocytes, B cells (total), T helper 1 (TH1) TBet+ T cells, and CD4+ 
T cells (total) in response to optogenetic stimulation (Fig. 6, C 
and D). These findings indicate that CRH neuronal stimulation altered 
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Novelty Male Female High-fat diet (HFD) Rat bedding (RB) TMT Restraint (Res) EPM open arm Grabbing (Grab)
Fig. 3. CRHPVN and HcrtLH neuronal activity during exposure to salient stimuli. (A and B) CRHPVN neurons and (C and D) HcrtLH neurons respond to distinct stimuli. 
Note aversive stimuli including predator fox odor (TMT), restraint stress (Res), EPM open arm (mimicking anxiety condition), and manual grabbing (Grab) lead to strong 









Li et al., Sci. Adv. 2020; 6 : eabc2590     9 September 2020
























15-ms 473-nm light pulse at 0.1 Hz for 6 hours

































































































































































































































































































































Fig. 4. Optogenetic stimulation of CRHPVN neurons elicits insomnia-like behavior. (A) Diagram of viral injection and fiber placement for optogenetic stimulation 
of Hcrt neurons in Hcrt::Cre mice. (B to D) Prolonged mild optogenetic stimulation of HcrtLH neurons had no significant effect on sleep/wake pattern in Hcrt::Cre mice. 
(E) Diagram of viral injection and fiber placement for optogenetic stimulation of LH-projecting CRHPVN neurons in CRH::Cre mice. (F to H) Prolonged mild optogenetic 
stimulation of CRHPVN neurons elicited consolidated wakefulness in CRH::Cre mice. (I) Diagram of viral injection and fiber placement for optogenetic stimulation of CRHPVN 
neurons projecting to LH in CRH::Cre-ATA3 mice without Hcrt neurons. (J to L) Prolonged mild optogenetic stimulation of CRHPVN LH-projecting neurons significantly 
increased the amount of wakefulness in the absence of Hcrt neurons. (M) Diagram of viral injection and fiber placement for optogenetic stimulation of LH-projecting 
CRHPVN neurons with crh gene disrupted. (N to P) Disruption of crh gene in CRHPVN neurons compromised the strong wakefulness-promoting effect elicited by stimulating 
LH-projecting CRHPVN neurons in CRH::Cre-Cas9 mice. (Q to S) Prolonged mild optogenetic stimulation of LH-projecting CRHPVN neurons but not Hcrt neurons signifi-
cantly increased wake amount. Absence of Hcrt neurons or CRISPR-Cas9–mediated disruption of crh gene in CRHPVN neurons compromised this effect (Q, †P < 0.0001; 
R, †P < 0.0001; S, **P = 0.0072). (B to D, F to H, J to L, and N to P) Linear mixed-effects model followed by Šidák’s multiple comparisons, dark phase indicated by gray 
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components of both the innate and adaptive immune systems. CRH 
neuron stimulation may alter immune cell distribution through 
several mechanisms including alteration of intracellular signaling 
responses implicated in the mobilization, adhesion, proliferation, 
and survival of these cells (36).
We next investigated the effect of CRHPVN neuron stimulation 
on the activity of key signaling pathways implicated in the immune 
response to stress, including elements of the nuclear factor B (NFB), 
mitogen-activated protein kinase (MAPK), and Janus kinase (JAK)/
signal transducer and activator of transcription (STAT) signaling 
pathways. CRH neuron stimulation promoted expression of IB (in-
hibitor of nuclear factor B) in nearly all cell types examined (Fig. 6B, 
left panel, and fig. S8), consistent with the known inhibitory effects 
of glucocorticoids on NFB signaling (37, 38). In addition, optoge-
netic stimulation down-regulated pSTAT6 protein expression in many 
immune cell subsets, including B cells, CD4+, and CD8+ T cells, and 
NK cells, consistent with prior observations of direct interactions 
between the glucocorticoid receptor and STAT6 (39). The inhibi-
tion of NFB and STAT6 signaling responses in T cells and mono-
cyte subsets, as well as the observed reductions in the numbers of 
circulating CD4+ T cells, B220+ B cells, NK cells, and monocyte sub-
sets suggest that CRH neuronal stimulation promoted widespread 
immunosuppression consistent with known glucocorticoid responses 
(40). Our observation of central optogenetically induced immuno-
suppression is consistent with an enhancement of glucocorticoid 
signaling by physical restraint stress as reported earlier (41). Therefore, 
we identified a neural substrate for stress-induced immunosuppression.
DISCUSSION
In this study, we find that the CRHPVN-HcrtLH pathway plays a cru-
cial role underlying stress-induced insomnia/hyperarousal and sys-
temic immunosuppression. We showed that CRHPVN neurons are 
sufficient but not necessary to trigger HcrtLH neuronal activity. We 
further demonstrated that optogenetic activation of CRHPVN neu-
rons projecting to the LH elicits long-lasting wakefulness mimick-
ing insomnia/hyperarousal induced by stress exposure. We found 
that CRH release from PVN neurons is necessary for optogenetically 
evoked hyperarousal and restraint stress–induced insomnia. These 
observations are in line with earlier work showing that stress induces 
CRH release in the PVN (42), and knockdown of CRH attenuates 
stress-induced social avoidance (43). In addition, ablation of Hcrt 
neurons partially reduces the amount of wakefulness elicited by op-
togenetically stimulating CRHPVN neurons projecting to LH and de-
creases the latency to NREM sleep onset following restraint stress. 
Our work highlights that the CRHPVN signaling pathway is a prom-
inent target for the treatment of insomnia/hyperarousal and stress- 
induced changes in systemic physiology.
Optical dissection of CRHPVN-HcrtLH circuitry in insomnia 
induced by stress
cFos staining of brain slices following restraint stress informed us 
that the hyperactivities of CRHPVN and HcrtLH neurons are poten-
tially implicated in stress-induced insomnia pathology. Many brain 
nuclei including hypocretinergic (5), aminergic (6–8), and basal fore-
brain cholinergic neurons (9, 10) are capable of switching arousal 




















































































































































































































Fig. 5. Disruption of the CRHPVN-HcrtLH circuitry significantly reduces the latency to NREM sleep onset following a 10-min restraint session without affecting the 
general sleep/wake pattern. (A) Absence of Hcrt neurons or disruption of crh gene in CRHPVN neurons significantly reduced the latency to NREM sleep onset after a 
10-min restraint stress session. (B to J) A 10-min restraint stress session did not alter the general sleep architecture of mice with intact (B to D) or disrupted CRHPVN-HcrtLH 
circuitry (E to J). (A) One-way ANOVA followed by Šidák’s multiple comparisons, paired t test between nonrestraint and restraint for a given genotype; (B to J) linear 
mixed-effects model followed by Šidák’s multiple comparisons, dark phase indicated by gray shielding; *P < 0.05, **P < 0.01, ***P < 0.005, †P < 0.0005; n = 6 mice for 
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states from sleep to wake. However, the optogenetic stimulation 
paradigms used in these experiments usually consist of multiple 
light pulses at frequencies mimicking or above their natural neuro-
nal firing rates, and insomnia/hyperarousal has not been reported 
following optogenetic stimulation of these brain nuclei. Strong op-
togenetic stimulations (higher light intensity, higher frequencies, and 
multiple pulses/train) of Hcrt neurons reliably promote and consol-
idate wakefulness in Hcrt::Cre mice (44). To avoid a potential satu-
ration of wakefulness by stimulating this circuitry, we used a mild 
stimulation paradigm (10-mW, 15-ms pulse at 0.1 Hz for 6 hours) 
to dissect either node of the CRHPVN-HcrtLH pathway in sleep/wake 
regulation. Although this mild stimulation paradigm was insufficient 
to promote wakefulness in Hcrt::Cre mice, the same stimulation of 
CRHPVN neurons projecting to LH where Hcrt neurons are located 
markedly elevated the arousal level mimicking insomnia under stress. 
Our observation is consistent with an earlier report showing that a 
single central administration of CRH causes long-lasting wakeful-
ness (30). We further investigated the specific role of Hcrt neurons 
and the crh gene in CRHPVN neurons in the same stimulation sce-
nario. Genetic ablation of Hcrt neurons significantly reduced the 
wakefulness amount upon optogenetic stimulation of LH-projecting 
CRHPVN neurons. The partial compromise of hyperarousal by genetic 
ablation of Hcrt neurons indicates CRH exerts arousal-promoting 
effect through other downstream neurons besides HcrtLH neurons. 
For example, activation of neurons expressing neurotensin inter-
mingled with Hcrt neurons in the LH has been reported to increase 
wake amount (45). Notably, CRISPR-Cas9–mediated knockdown of 
the crh gene completely abolished the hyperarousal phenotype upon 
optogenetic stimulation of LH-projecting CRHPVN neurons. These 
observations highlight that the hormone CRH plays a pivotal role in 
stress-induced insomnia/hyperarousal. Fiber photometry recording 











































































































Fig. 6. CRHPVN activation drives changes in systemic immunity consistent with immunosuppression. (A) Cell subpopulation distribution in the pooled dataset based 
on all samples. (B) Composite tSNE plots of intracellular protein expression from control and optogenetically stimulated mice for IB (left), pSTAT6 (middle), and pCREB 
(right). (C) Distribution of circulating innate immune cells (ICs) at baseline (black bars) and in response to CRH neuronal stimulation (red bars), including NK1.1+ NK cells, 
MHCII+ dendritic cells, Ly6CLow patrolling monocytes, and Ly6CHi inflammatory/phagocytic monocytes. (D) Distribution of circulating adaptive ICs at baseline (black bars) 
and in response to CRH neuronal stimulation (red bars), including B lymphocytes (B220+), was decreased. T lymphocyte subsets altered include TH1 TBet+ cells and CD4+ 
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transitions, but highly active under stress. The concomitant HcrtLH 
neuronal activity under stress suggests that CRHPVN neurons recruit 
Hcrt neurons to mediate hyperarousal. The responses of HcrtLH neu-
rons to neutral/positive stimuli indicate that these neurons could be 
engaged in various conditions requiring vigilance independent of 
valence.
Neural substrates of stress-induced peripheral 
immunosuppression
An earlier study has linked the activation of reward-related VTA 
dopaminergic neurons to an enhancement of innate and adaptive 
immunity including elevated antibacterial activity of monocytes and 
macrophages (46). Reciprocally, stress-induced insomnia is often as-
sociated with deficits in immune function in humans (47). However, 
the neural substrates linking stress, arousal, and immunity are poorly 
understood. As we discussed above, CRH neurons in the PVN serve 
as a key node in the behavioral and physiological stress response in 
part via the promotion of downstream glucocorticoid secretion from 
the adrenal cortex. We identified the CRHPVN-HcrtLH pathway as a 
critical regulator coupling stress to arousal and protracted insom-
nia. A recent study showed that hypocretin-null mice developed mono-
cytosis, whereas Hcrt supplementation decreased the concentration 
of Ly6CHi monocytes (48) and therefore established a link between 
the hypocretinergic system and immune regulation. Our observa-
tion that stimulation of CRHPVN soma resulted in dynamic changes 
in immune cell distribution and functional responses (e.g., reduc-
tion in circulating CD4+ T cells and increases in IB expression) 
is consistent with known immunosuppressive effects of glucocor-
ticoids. Acute stress appears to prime immunity, whereas chronic 
stress usually suppresses immune function. Given a mild optoge-
netic stimulation of CRHPVN neurons is sufficient to elicit insomnia/
hyperarousal, a stronger stimulation paradigm that we used to study 
immune function likely overwhelmed the CRHPVN circuitry, and thus 
mimicking the effect of chronic stress on immune function. Further 
studies are needed to understand how different stimulation paradigms 
influence systemic and tissue-specific immune cell populations.
An alternative explanation (beyond glucocorticoid up-regulation) 
for the changes we observed may depend on CRHPVN-mediated ac-
tivation of the sympathetic nervous system. CRHPVN neurons drive 
downstream sympathetic activation via projections to the brainstem 
nucleus of the solitary tract (49). Postganglionic sympathetic nerves 
have well-known immunomodulatory effects, driven largely by the 
effect of their neurotransmitter product, norepinephrine (49). In early 
studies, the effects of CRH on the immune system appeared to be 
dependent on the sympathetic nervous system, as chemical sympa-
thectomy and pharmacological blockade of -adrenergic receptors 
reversed the observed effect of CRH on immune function (50). If 
the immunosuppressive phenotype we observed depends on sym-
pathetic activation, then -adrenergic blockade may additionally pre-
vent immune dysfunction associated with stress and insomnia [e.g., 
as in (51)]. Recently, a study demonstrated that CRHPVN neurons can 
influence the development and function of peripheral antibody–
producing B cells (plasma cells) via their projections to the splenic 
nerve (52). Delineating how these neurons differentially promote 
enhancement of humoral immunity in one condition and elicit broad 
immunosuppression in another is still an open question that needs 
to be addressed. 
Together, we reveal that the CRHPVN-HcrtLH pathway plays a 
critical role in hyperarousal via optical interrogation of sleep, and 
systemic immunity with CyTOF analysis of immune factors. 
Therefore, we identify a shared neural substrate for insomnia 
and immunosuppression under stress.
MATERIALS AND METHODS
Animals
Experiments were performed following the protocols approved by 
the Stanford University Animal Care and Use Committee in accor-
dance with the National Institutes of Health Guide for the Care and 
Use of Laboratory Animals. Discomfort, distress, and pain were min-
imized with anesthesia and analgesic medications. Young adult (3 to 
6 months) male mice were used in this study. Mice were housed 
in a temperature- and humidity-controlled animal facility with a 
12-hour/12-hour light/dark cycle (9:00 light on, 21:00 light off). 
Standard laboratory mouse food pellets and water were available ad 
libitum. Hcrt-IRES-Cre knock-in heterozygotes (Hcrt::Cre) (12), 
Hcrt/orexin/ataxin-3 mice (ATA3) (28), and CRH::Cre [B6(Cg)- 
Crhtm1(cre)Zjh/J, JAX stock no. 012704], AVP::Cre [B6.Cg-Avptm1.1(cre)Hze/J, 
JAX stock no. 023530], and OXT::Cre [B6;129S-Oxttm1.1(cre)Dolsn/J, 
JAX stock no. 024234] were backcrossed onto C57BL/J backgrounds. 
CRH::Cre-ATA3 mice were generated by crossing CRH::Cre het-
erozygotes with ATA3 heterozygotes. CRH::Cre-Cas9 mice were 
generated by crossing CRH::Cre heterozygotes with Cas9 homozy-
gotes [B6J.129(B6N)-Gt(ROSA)26Sortm1(CAG-cas9*,-EGFP)Fezh/J, JAX 
stock no. 026175]. Vgat::Cre-tdTomato mice were generated by cross-
ing Vgat::Cre [Slc32a1tm2(cre)Lowl/J, stock no. 016962] heterozygotes 
with Ai 14 [B6;129S6-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J, JAX 
stock no. 007908] homozygotes.
EEG/EMG electrode fabrication and implantation
Mini-screw (US Micro Screw) was soldered to one tip of an insulated 
mini wire with two tips exposed, and the other tip of the mini-wire 
was soldered to a golden pin aligned in an electrode socket. A mini-
ring was made on one side of an insulated mini-wire with the other 
side soldered to a separate golden pin in the electrode socket. Each 
electrode socket contains four channels with two mini-screw chan-
nels for EEG recording and two mini-ring channels for EMG record-
ing. The resistance of all the channels was controlled with a digital 
multimeter (Fluke) lower than 1.5 ohms for ideal conductance. Mice 
were mounted onto an animal stereotaxic frame (David Kopf In-
struments) under anesthesia with a mixture of ketamine (100 mg/kg) 
and xylazine (20 mg/kg). Two mini-screws were placed in the skull 
above the frontal [anteroposterior (AP), −2 mm; mediolateral (ML), 
±1 mm] and temporal (AP, 3 mm; ML, ±2.5 mm) cortices for sam-
pling EEG signals, and two mini-rings were placed in the neck muscles 
for EMG signal acquisition. Electrode sockets were secured with 
Metabond and dental acrylic on the skull for recording in freely moving 
mice. After surgery, mice were administered with buprenorphine-SR 
(0.5 mg/kg; 30 min before and 24 to 48 hours after surgery, subcu-
taneously) for pain relief.
EEG/EMG recording and analysis
EEG/EMG signals were sampled at 256 Hz with VitalRecorder (Kissei 
Comtec Co.) following amplification through an amplifier with mul-
tiple channels (Grass Instruments). The band-pass was set between 
0.1 and 120 Hz. Raw EEG/EMG data were exported to MATLAB 
(MathWorks, Natick, MA, USA) and analyzed with custom scripts 
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behavioral states. For optogenetic and fiber photometry recording 
experiments, simultaneous EEG/EMG signals were recorded to de-
termine behavioral states. The raw EEG/EMG signals with/without 
GCaMP6f traces were imported to MATLAB for offline analysis.
Virus injection and fiber optic implantation
Monosynaptic tracing of inputs to HcrtLH neurons
To determine the cell type in the PVN with direct innervation of 
HcrtLH neurons, we used the EnvA-pseudotyped glycoprotein (G)–
deleted rabies virus (EnvA + RVdG) tracing strategy (21). First, a 
mixture of AAV-5 EF1-Flex TVA-mCherry (AAV67, lot no. 388b, 
2.5 × 1012 gc/ml (genome copies/ml), Stanford virus core) and AAV-
8(Y733F)-CAG Flex RabiesG (AAV-59, lot no. 1489, 5.0 × 1013 gc/ml, 
Stanford virus core) was injected to the LH of young (3 to 6 months) 
male Hcrt::Cre mice to target the Hcrt field [AP, −1.35 mm; ML, 
±0.95 mm; dorsoventral (DV), −4.85 to DV, −5.15 mm) under an-
esthesia and analgesic as described above. Two weeks later, the same 
mice were injected with EnvA G-deleted rabies green fluorescent 
protein (GFP) (6.04 × 107 gc/ml, Salk Institute Gene Transfer Targeting 
and Therapeutics Core) at the coordinates same with the first injec-
tion. One week after the second injection, colchicine (1.0 l of 7 g/ml 
solution per hemisphere, for PVN CRH/AVP/OXT neuropeptide 
immunostaining) was injected to the lateral ventricles (AP, −0.65 mm; 
ML, ±0.95 mm; DV, −2.55 mm) under anesthetics and analgesic as 
described above. Then, mice were anesthetized and perfused 24 to 
48 hours later for immunostaining.
AAV-retro tracing of LH upstream neurons
PVN is known as a hub containing intermingled CRH, AVP, and 
OXT neurons (19). To further validate that the LH receives neuronal 
projections from PVN, we injected AAV-Retro-EF1-DIO-hChR2 
(C128S/D156A)-eYFP (AAV-Retro, Stanford Virus Core, 3.3 × 
1013 gc/ml, lot no. 3908) to the LH containing Hcrt field (AP, −1.35 mm; 
ML, ±0.95 mm; DV, −5.15 mm) of young male CRH::Cre, AVP::Cre, 
OXT::Cre mice, respectively, under anesthetics and analgesic as 
aforementioned. Three weeks after injection, colchicine (1.0 l of 
7 g/ml solution per hemisphere, for PVN CRH/AVP/OXT neuro-
peptide immunostaining) was injected to the lateral ventricles 
(AP, −0.65 mm; ML, ±0.95 mm; DV, −2.55 mm). Then, mice were 
anesthetized and perfused 24 to 48 hours later for immunostaining.
Fiber photometry
For fiber photometry recording from HcrtLH [also known as orexin 
(53, 54)] neurons in Hcrt::Cre mice, 0.3 l of AAV vectors carrying 
genes encoding GCaMP6f (AAV-DJ-EF1-DIO-GCaMP6f, 1.1 × 
1012 gc/ml, Stanford Virus Core, lot no. 3725) was delivered to left 
(L)/right (R) LH (AP, −1.35 mm; ML, ±0.95 mm; DV, −5.15 mm) of 
young male Hcrt::Cre mice with a 5-l Hamilton microsyringe, and 
a glass fiber (400-m core diameter, Doric Lenses) was implanted 
with the tip at the injection site for GCaMP6f signal acquisition later 
on. For recording from CRHPVN neurons, the same virus was injected 
to L/R PVN (AP, −0.90 mm; ML, ±0.30 mm; DV, −4.66 mm), and 
glass fiber was placed at the same site of young CRH::Cre mice. EEG 
and EMG electrodes were implanted after securing the fiber optic 
with meta-bond and dental acrylic. Mice were housed in their home 
cages to recover for at least 2 weeks to get sufficient viral expres-
sion before connection to the EEG/EMG recording cables and fiber 
photometry recording patch cord.
Optogenetic experiments
For optogenetic experiments, 0.3 l of AAV-DJ-EF1-DIO-
hChR2(H134R)-eYFP viruses (ChR2-eYFP, 6.5 × 1012 gc/ml, Stanford 
Virus Core, lot no. 4176) was delivered to LH (AP, −1.35 mm; ML, 
±0.95 mm; DV, −5.15 mm) of anesthetized young (3 to 6 months) 
male Hcrt::Cre mice according to stereotaxic coordinates deter-
mined on Kopf stereotaxic frame with a 5-l Hamilton micro-
syringe. A glass fiber (200-m core diameter, Doric Lenses, Franquet, 
Québec, Canada) was implanted with the tip right above the injec-
tion site for optogenetic stimulations later on. For stimulating 
CRHPVN neurons projecting to LH, AAV-Retro-EF1-DIO-
hChR2(C128S/D156A)- eYFP (AAV-Retro, Stanford Virus Core, 
3.3 × 1013 gc/ml, lot no. 3908) was injected to LH with the same 
coordinates for Hcrt::Cre mice. A glass fiber (200-m core diameter, 
Doric Lenses, Franquet, Québec, Canada) was implanted with the 
tip right above the CRHPVN neurons (AP, −0.90 mm; ML, ±0.30 mm; 
DV, −4.3 mm) for optogenetic stimulations of LH- projecting 
CRHPVN neurons later on. After fixation of glass fiber and EEG/EMG 
electrode implantation, mice were allowed to recover for at least 
2 weeks to get sufficient viral expression before connecting to the 
EEG/EMG recording cables and optical stimulation patch cord.
CRISPR-Cas9–mediated crh gene disruption in  
CRH::Cre-Cas9 mice
Crh gene target sites for CRISPR-Cas9 were designed by CHOPCHOP 
(http://chopchop.cbu.uib.no) (55). The target sequences were as 
follows: sgCRH1, 5′-ATGCGGATCAGAACCGGCTG-3′; sgCRH2, 
5′-CAACTCCACGCCCCTCACCG-3′. Oligonucleotides encoding 
guide sequences are purchased from Integrated DNA Technologies 
(IDT) and cloned individually into the Bbs I fragment of pX458 
[Addgene plasmid 48138 (56)]. U6-sgCRH1and U6-sgCRH2 frag-
ments were polymerase chain reaction amplified, respectively, using 
pX458-sgCRH as a template. Amplified fragments were cloned tan-
demly into Mlu I–digested pAAV-EF1-DIO-mCherry (Addgene 
plasmid 20299) by Gibson assembly method. The primers used were 
as follows: Gibson1-F, 5′-TAGGGGTTCCTGCGGCCGCAGAGG-
GCCTATTTCCCATG-3′; Gibson1-R, 5′-ATAGGCCCTCGGTA-
CCAAAAATCTCGCC-3′; Gibson2-F, 5′-TTTTTCTAGAGAGG-
GCCTATTTCCCATG-3′; Gibson2-R, 5′-ATCCATCTTTGCAA - 
AGCTTAAAAAATCTCGCCAACAAGTTG-3′. AAV constructs 
carrying nontargeting guide sequences were used as control (29). 
pAAV-U6-sgCRH1-U6-sgCRH2-EF1-DIO-mCherry and pAAV-
U6-sgControl-U6-sgControl-EF1-DIO-mCherry were packaged into 
AAV-DJ by the gene vector and virus core at Stanford University. 
AAV-DJ-U6-sgControl-EF1-DIO-mCherry (0.6 l) (5 × 1012 gc/ml, 
lot no. 4354) and AAV-DJ-U6-sgCRH12-EF1-DIO-mCherry 
viruses (3 × 1012 gc/ml, lot no. 4553) were respectively injected to 
PVN (AP, −0.90 mm; ML, ±0.30 mm; DV, −4.5 + −4.8 mm; 0.3 l 
each depth) unilaterally of the CRH::Cre-Cas9 mice for crh gene 
disruption validation. Three weeks after the virus injection, colchi-
cine (1.0 l of 7 g/ml solution per hemisphere, for CRH neuro-
peptide immunostaining) was injected to the lateral ventricles 
(AP, −0.65 mm; ML, ±0.95 mm; DV, −2.55 mm). Then, mice were 
anesthetized and perfused 24 to 48 hours later for immunos-
taining. For optogenetic stimulation of LH-projecting CRHPVN 
neurons with crh gene disrupted, 0.6 l of AAV-DJ-U6-sgCRH12-
EF1-DIO-mCherry viruses was injected to the L/R PVN (−0.90 mm; 
ML, ±0.30 mm; DV, −4.5 + −4.8 mm; 0.3 l each depth) unilaterally 
of CRH::Cre-Cas9 mice under anesthesia, and 0.3 l of AAV-Retro-
EF1-DIO-hChR2(C128S/D156A)-eYFP viruses was injected to the 
LH (AP, −1.35 mm; ML, ±0.95 mm; DV, −5.15 mm) of the same hemi-
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targeting PVN infected by viral vectors was implanted for optogenetic 
stimulation of crh gene ablated CRHPVN neurons projecting to LH, 
and EEG/EMG electrodes were implanted for EEG/EMG recording 
later on. For the restraint stress on sleep experiment, 0.6 l of AAV-
DJ-U6-sgCRH12- EF1-DIO-mCherry viruses was injected to the 
PVN (−0.90 mm; ML, ±0.30 mm; DV, −4.5 + −4.8 mm; 0.3 l each 
depth) bilaterally of CRH::Cre-Cas9 mice under anesthesia, and EEG/
EMG electrodes were implanted for sleep pattern recording afterward.
Restraint stress and sleep recording
A well-established noninvasive restraint paradigm was used to gen-
erate acute stress in mice (18). For the cFos immunostaining exper-
iment, nine young adult male wild-type (WT) mice (3 to 5 months) 
were individually placed head first into a well-ventilated 50-ml Falcon 
conical tube with a narrow open window on top placed in their home 
cages. After a 10-min restraint session, mice were immediately re-
leased from the restraint tubes. Mice were randomly separated into 
three groups and were perfused at 20 min (n = 3), 80 min (n = 3), 
and 140 min (n = 3) after the restraint stress termination. For eval-
uating the impact of restraint stress on latency to sleep onset and 
general sleep architecture, young adult male mice (3 to 6 months, 
CRH::Cre, CRH::Cre-ATA3, CRH::Cre-Cas9 infused with crh gene 
disrupted bilaterally in CRHPVN neurons) with EEG/EMG implants 
(for sleep pattern monitoring) were exposed to the restraint tubes 
with a narrow window on top for EEG/EMG cable sliding. During 
the entire restraint procedure, mice were in a natural body position 
without physical harm in their home cages. The restraint stress last-
ed for 10 min at the beginning of the light phase when mice have a 
strong drive for sleep. EEG/EMG signals were recorded starting from 
the onset of restraint stress. Mice were released from the restraint 
tubes immediately after a 10-min restraint session.
Salient stimuli
GCaMP6f signal was recorded from CRHPVN neurons in male CRH::Cre 
mice and from HcrtLH neurons in male Hcrt::Cre mice housed indi-
vidually with 1-week habituation to fiber patch cord. GCaMP6f sig-
nal was sampled for 4 min each session with 2 min as baseline and 
2-min exposure to salient stimuli including a 15-ml novel Falcon 
tube (novelty), novel male mouse, novel female mouse, HFD (in a 
small petri dish), rat bedding (in a small petri dish), restraint (mouse 
placed in a well-ventilated 50-ml Falcon conical tube with a narrow 
window for fiber patch cord sliding), TMT (a small piece of filtra-
tion paper with 5-l TMT in a small petri dish), and manual grab-
bing. For the EPM open arm exposure, mouse was transferred from 
the home cage onto the open arm of the EPM with the entrance to 
EPM center blocked. Salient stimuli were removed immediately from 
the mice after 2 min. Introduction of salient stimuli to each individ-
ual mouse was randomly shuffled.
Fiber photometry signal acquisition and analysis
Following recovery and habituation to EEG/EMG cable lead and 
fiber optic patch cord (400-m core diameter, Doric Lenses), mice 
expressing Cre-dependent GCaMP6f were connected to EEG/EMG 
recording setup and custom-built fiber photometry setup (44), re-
spectively. Briefly, a 470-nm light-emitting diode (LED) (M470D3, 
Thorlabs, NJ, USA) was sinusoidally modulated at 211 Hz and 
passed through a GFP excitation filter followed by a dichroic mirror 
(MD 498, Thorlabs) for reflection. The light stream was sent through a 
high numerical aperture (NA) (0.48), large core (400 m) optical 
fiber patch cord (Doric Lenses, Québec, Canada), which was con-
nected with a zirconia connector (Doric Lenses, Québec, Canada) 
to the dental acrylic–secured fiber optic implant (0.48 NA, 400 m, 
Doric Lenses, Québec, Canada) with the tip above the injection site 
targeting CRHPVN or HcrtLH neurons. Separately, a 405-nm LED was 
modulated at 531 Hz and filtered by a 405-nm band-pass filter and 
sent through the optical fiber patch cord to mouse brain to evoke 
reference fluorescence, which is independent of Ca2+ release. GCaMP6f 
fluorescence and reference fluorescence were sampled by the same 
fiber patch cord through a GFP emission filter (MF525-39, Thorlabs), 
and center aligned to a photodetector (Model 2151, Newport, Irvine, 
CA, USA) with a lens (LA1540-A, Thorlabs). The analog signals were 
amplified by two lock-in amplifiers for GFP fluorescence and refer-
ence fluorescence, respectively (model SR380, Stanford Research 
Systems, Sunnyvale, CA, USA). MATLAB-based custom software 
was used to control the LEDs and sample both the GFP fluorescence 
and reference fluorescence through a multifunction data acquisition 
device (National Instruments, Austin, TX, USA) with 256-Hz sam-
pling frequency in a real-time manner. F/F was obtained by sub-
tracting the reference fluorescence signal from the 470-nm excited 
GFP emission signal to remove the system interference. GCaMP6f 
from CRHPVN or HcrtLH neurons, and simultaneous EEG/EMG rec-
ordings were conducted between 14:00 and 18:00 during the light 
phase. GCaMP6f signals were staged to different behavioral state 
transitions based on the simultaneously recorded EEG/EMG sig-
nals. The behavioral state transition category includes NREM to 
brief wake, NREM to REM, NREM to long wake, REM to brief wake, 
REM to long wake, and wake to NREM. Traces for each behavioral 
state transition were plotted with transition time point defined as 
0 for CRH::Cre and Hcrt::Cre mice. For GCaMP recording during 
salient stimuli challenges, time of introduction of the stimuli to the 
mice was defined as time 0. A z score was calculated by subtracting 
the mean value of GCaMP6f after time 0 from the mean value of 
GCaMP6f trace before time 0.
Optogenetic stimulation
After recovery, mice injected with viruses expressing Cre-dependent 
ChR2-eYFP were connected to EEG/EMG recording cables and fiber 
optic patch cord (200-m core diameter, Doric Lenses) for 1-week 
acclimation in cages with open top, which allowed mice to move freely. 
Following acclimation, EEG and EMG were recorded for 24 hours 
covering an entire light/dark cycle with 15-ms 10-mW (Laserglow, 
calibrated with Thorlabs light meter) 473-nm light pulse optogenetic 
stimulation at 0.1 Hz for 6 hours starting from the beginning of the 
light phase.
Histology
For in vivo experiments, upon accomplishment of recordings, mice 
were perfused under anesthesia (100 mg/kg ketamine and 20 mg/kg 
xylazine mixture) with ice-cold 1× phosphate-buffered saline (PBS) 
to verify the viral expression and glass fiber placement. Brains were 
rapidly extracted, postfixed with 4% paraformaldehyde (PFA) at 4°C 
overnight, and equilibrated in 30% sucrose in PBS containing 0.1% 
NaN3. Then, brains were sectioned at −22°C with a cryostat (Leica 
Microsystems) at a thickness of 35 m. Slices were collected from 
anterior to posterior consecutively to 24-well plates containing 
1× PBS with 0.1% NaN3, covered with aluminum foil, and stored at 
4°C until immunostaining and imaging. Primary polyclonal anti-
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immunoglobulin G (IgG)] and primary polyclonal antibodies against 
cFos (host: rabbit, catalog no. SC-52, lot no. J0815; host: goat, cata-
log no. SC-52-G, lot no. F1716) were purchased from Santa Cruz 
Biotechnology, INC. Primary polyclonal antibody against cFos (host: 
rabbit, catalog no. 26209, lot no. 1714001), primary polyclonal anti-
body against CRH (host: rabbit, catalog no. 20084, lot no. 533038), 
primary polyclonal antibody against AVP (host: rabbit, catalog no. 
20069, lot no. 1911001), and primary polyclonal antibody against 
OXT (host: rabbit, catalog no. 20068, lot no. 1607001) were pur-
chased from ImmunoStar. Secondary antibodies Alexa Fluor 594 
Donkey anti-goat IgG (H + L, catalog no. A-11058), Alexa Fluor 
594 donkey anti-rabbit IgG (H + L, catalog no. A32754), Alexa Fluor 
488 donkey anti-rabbit IgG (H + L, catalog no. A-21206), and Alexa 
Fluor 647 donkey anti-rabbit IgG (H + L, catalog no. A-31573) 
were purchased from Invitrogen (manufacturer: Life Technologies). 
Appropriate antibodies were selected for staining depending on the 
experimental paradigms. For the WT mice used for restraint stress, 
sections around PVN and LH were washed in 1× PBS for 5 min, 
three times, and incubated in a blocking solution of 1× PBS with 
0.3% Triton X-100 (PBST) and 4% bovine serum albumin for 1 hour. 
Following that, CRH primary antibody and OX-A/Hcrt-1 primary 
antibody were added to the wells containing slices around PVN and 
wells containing LH slices, respectively, and cFos primary antibody was 
added to both PVN slice–containing wells and LH slice–containing 
wells with blocking solution (1:800) overnight. On the second day, 
sections were washed in 1× PBS for 5 min, three times, and incubated 
in blocking buffer for 2 hours. After blocking, secondary antibody 
was added to the blocking buffer for 2 hours (dilution 1:800). After 
three times of 5-min 1× PBS washing, brain sections were mounted 
onto gelatin-coated slides, covered with Fluoroshield containing 4′,6- 
diamidino-2-phenylindole Mounting Media (Sigma-Aldrich, F6057) 
and coverglass for imaging with a widefield microscope (Zeiss 
AxioImager, Germany) for the entire section or LSM710 confocal 
microscope for enlarged visualization (Zeiss, Germany). For cell type 
determination in PVN of Vgat::Cre-Ai14 mice, colchicine (1.0 l of 
7 g/ml solution per hemisphere, for PVN CRH/AVP/OXT neuro-
peptide staining) was injected to the lateral ventricles (AP, −0.65 mm; 
ML, ±0.95 mm; DV, −2.55 mm). Then, mice were anesthetized and 
perfused within 24 to 48 hours for immunostaining.
Mass cytometry by time of flight
CRH::Cre mice were equipped with EEG/EMG electrodes as de-
scribed previously. AAVs encoding the optogenetic actuator ChR2 
(AAV-DJ-DIO-EF1-ChR2-eYFP; lot no. 5227; 4.12 × 1012 gc/ml) 
were infused into the paraventricular nucleus [unilateral; 0.4 l; 
AP, −0.90 mm; ML, ±0.25 mm; DV, −4.85 mm (injection); DV, 
−4.6 mm (optic fiber)] over the course of 3 min followed by 10 min 
for viral distribution to the tissue. Then, a fiber optic implant (200-m 
diameter, 5.5-mm length, Doric Lenses Inc.) was slowly lowered and 
cemented in place above the PVN. Mice were allowed to recover for 
at least 3 weeks before starting the experiment.
Following recovery, 15-ms 10-mW (Laserglow, calibrated with 
Thorlabs light meter) 473-nm light pulses at 10 Hz (10 s on, 20 s off) 
were delivered to the PVN for 1 hour, and then, whole blood was col-
lected 3 hours following the start of stimulation using microcapillary 
tubes (retro-orbital bleed; approximately 350 l of blood). Blood was 
immediately stabilized using a protein stabilization reagent, allowed 
to sit for 10 min and then placed at −80°C in cryovials until further 
processing. Red blood cells (RBCs) were lysed using 1× thaw-lyse 
buffer (Smart Tube Inc., San Carlos, CA) in ddH2O. After lysing, 
cells were pelleted at 600g for 5 min at room temperature (RT). RBC- 
depleted samples were barcoded using palladium isotopes. In brief, 
cells were washed with cell staining media (CSM), 1× PBS, and 1× PBS 
containing 0.02% saponin and then placed into a deep well block. 
Unique barcoding reagents were added to each well of the block con-
taining cells from each mouse and incubated for 15 min at RT. After in-
cubation, cells were washed with CSM and then resuspended via brief 
vortexing. Then, all samples were pooled into a single fluorescence- 
activated cell sorting (FACS) tube for the next staining step. After 
washing and pelleting the pooled cells, 150 l of Fc block was added, 
and cells were incubated at RT with gentle shaking (600 rpm) for 
10 min. Then, 300 l of the surface antibody mix (see table S1) was 
added, and cells were incubated at RT for 30 min with gentle shaking. 
Then, cells were washed, pelleted, and the supernatant was collected 
and discarded. To permeabilize cells for intracellular staining, 700 l 
of MeOH was added to the tube, and cells were incubated at 4°C for 
10 min. Then, cells were washed with 1× PBS and CSM, followed by 
incubation with the intracellular antibody mix (see table S1) for 30 min 
at RT with gentle shaking (600 rpm). Cells were washed and then a 
DNA intercalator (DVS # Inter-1X-natir) was added in a mixture of 
16% PFA/PBS. This mixture was incubated at 4°C overnight.
On the following day, the pooled sample was washed and then 
1× normalization “beta” beads were added and cells were strained 
into a new FACS tube. Cells were run on a Helios (Fluidigm) ma-
chine using the SuperSampler attachment. Following the run, the 
data were normalized to the normalization bead signal. Then, data 
were run through de-barcoder software (MATLAB; bead distance 
0.2) and individual .FCS files were gated and analyzed manually using 
ImmuneAtlas and Cytobank platforms. T-distributed stochastic 
neighbor embedding (tSNE) plots were generated for filtered singlet/ 
leukocyte (i.e., RBCs excluded) populations for each file and formed 
into a composite plot. In brief, .FCS files were arcsinh transformed 
(a = 0, b = 1/5, c = 0), and 3000 randomly selected events were sam-
pled for each file. T-distributed stochastic neighbor embedding (tSNE) 
was computed on the aggregated matrix with all events (3000 × 12 = 
36,000). The following parameters were used for tSNE in the RTsne 
package (https://CRAN.R-project.org/package=Rtsne): perplexity = 30, 
max_iter = 500. Then, the transformed coordinate events were 
mapped back to the sample they came from, as well as composite 
maps for each condition and the total population.
Statistical analysis
Hourly based sleep comparisons were analyzed by a linear mixed-effects 
model followed by Šidák’s multiple comparisons as described in a 
similar counterbalanced crossover design (44). One-way analysis of 
variance (ANOVA) followed by Šidák’s multiple comparisons was 
used to analyze alteration of sleep/wake amount for different exper-
imental paradigms, and latency to sleep onset. Paired Student’s t test 
was used for sleep/wake amount comparison between non-stim/
nonrestraint and stim/restraint datasets. CyTOF data were analyzed 
with the Holm-Šidák test. In the figures, *, **, ***, ****, and † indi-
cate P < 0.05, P < 0.01, P < 0.005, P < 0.001, and P < 0.0005, respec-
tively. All values were reported as means ± SEM.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/37/eabc2590/DC1
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